• Industry
    • BioValley the Place to be!
    • Excellence in Companies
    • Technology Parks
    • Tech Transfer Opportunities
    • Financial Opportunities
    • BioValley Services
  • Academia
    • BioValley the Place to be!
    • Excellence in Research
    • Tech Transfer Opportunities
    • Financial Opportunities
    • BioValley Services
  • Education
    • Excellence in Education
    • Primary/Secondary Training
  • About the Cluster
    • Who we are?
    • Our Services
    • Our Team
    • INTERREG Program
    • Downloads
    • Contact

NEW GRANT FOR DOMAIN THERAPEUTICS

By Sibylle | Published: 14 April 2014

DOMAIN-THERAPEUTICS_logo_BD230-fdblc Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces the receipt of a second grant of 230 000 dollars (USD) from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support its metabotropic glutamate receptor type III positive allosteric modulators program. The MJFF first supported the initial stages of this program in 2012 through a 300 000 dollars (USD) grant.

read the press release

This entry was posted in Non classé. Bookmark the permalink. Both comments and trackbacks are currently closed.
footer-home footer-contact footer-newsletter
right-footer
  • Site Map
  • Legal Informations